Use of preservative-free hyaluronic acid (Hylabak^®) for a range of patients with dry eye syndrome: experience in Russia

References

• [No authors listed]The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007)Ocul Surf20075759217508116
   PubMed Web of Science ®Google Scholar
• PaivaCSPflugfelderSCRationale for anti-inflammatory therapy in dry eye syndromeArq Bras Oftalmol200871899519274418
   PubMed Web of Science ®Google Scholar
• MurubeJNémethJHöhHThe triple classification of dry eye for practical clinical useEur J Ophthalmol20051566066716329048
   PubMed Web of Science ®Google Scholar
• BrzhevskyVVDry eye syndromeMaychukDYRed Eye SyndromeMoscow, Russian FederationOOO Publications Ophthalmology2010
   Google Scholar
• SommerHJJohnenJSchongenPStolzeHHAdaptation of the tear film to work in air-conditioned rooms (office-eye syndrome)Ger J Ophthalmol199434064087866260
   PubMedGoogle Scholar
• BrzheskyVVDry-eye syndrome in young people: the unsolved problem of modern ageModern Optometry200723843
   Google Scholar
• DoughtyMJGlavinSEfficacy of different dry eye treatments with artificial tears or ocular lubricants: a systematic reviewOphthalmic Physiol Opt20092957358319686307
   PubMed Web of Science ®Google Scholar
• SnibsonGRGreavesJLSoperNDTiffanyJMWilsonCGBronAJOcular surface residence times of artificial tear solutionsCornea1992112882931424647
   PubMed Web of Science ®Google Scholar
• NakamuraMHikidaMNakanoTItoSHamanoTKinoshitaSCharacterization of water retentive properties of hyaluronanCornea1993124334368306665
   PubMed Web of Science ®Google Scholar
• CondonPIMcEwenCGWrightMMackintoshGPrescottRJMcDonaldCDouble blind, randomised, placebo controlled, crossover, multicentre study to determine the efficacy of a 0.1% (w/v) sodium hyaluronate solution (Fermavisc) in the treatment of dry eye syndromeBr J Ophthalmol1999831121112410502570
   PubMed Web of Science ®Google Scholar
• AragonaPPapaVMicaliASantoconoMMilazzoGLong term treatment with sodium hyaluronate-containing artificial tears reduces ocular surface damage in patients with dry eyeBr J Ophthalmol20028618118411815344
   PubMed Web of Science ®Google Scholar
• JohnsonMEMurphyPJBoultonMEffectiveness of sodium hyaluronate eyedrops in the treatment of dry eyeGraefes Arch Clin Exp Ophthalmol200624410911215983814
   PubMed Web of Science ®Google Scholar
• VogelRCrockettRSOdenNLaliberteTWMolinaLSodium Hyaluronate Ophthalmic Solution Study GroupDemonstration of efficacy in the treatment of dry eye disease with 0.18% sodium hyaluronate ophthalmic solution (Vismed, Rejena)Am J Ophthalmol201014959460120346777
   PubMed Web of Science ®Google Scholar
• BaeyensVBronABaudouinCVismed/Hylovis Study GroupEfficacy of 0.18% hypotonic sodium hyaluronate ophthalmic solution in the treatment of signs and symptoms of dry eye diseaseJ Fr Ophtalmol201235412419 French22483761
   PubMed Web of Science ®Google Scholar
• TomlinsonAKhanalSRamaeshKDiaperCMcFadyenATear film osmolarity: determination of a referent for dry eye diagnosisInvest Ophthalmol Vis Sci2006474309431517003420
   PubMed Web of Science ®Google Scholar
• StahlUWillcoxMStapletonFRole of hypo-osmotic saline drops in ocular comfort during contact lens wearCont Lens Anterior Eye201033687520117960
   PubMed Web of Science ®Google Scholar
• AragonaPDi StefanoGFerreriFSodium hyaluronate eye drops of different osmolarity for the treatment of dry eye in Sjogren’s syndrome patientsBr J Ophthalmol20028687988412140209
   PubMed Web of Science ®Google Scholar
• TroianoPMonacoGEffect of hypotonic 0.4% hyaluronic acid drops in dry eye patients: a cross-over studyCornea2008271126113019034126
   PubMed Web of Science ®Google Scholar
• PapaVAragonaPRussoSComparison of hypotonic and isotonic solutions containing sodium hyaluronate on the symptomatic treatment of dry eye patientsOphthalmologica200121512412711244343
   PubMed Web of Science ®Google Scholar
• BaudouinCLabbéALiangHPaulyABrignole-BaudouinFPreservatives in eyedrops: the good, the bad and the uglyProg Retin Eye Res2010231233420302969
   PubMed Web of Science ®Google Scholar
• FurrerPMayerJMGurnyROcular tolerance of preservatives and alternativesEur J Pharm Biopharm20025326328011976014
   PubMed Web of Science ®Google Scholar
• GabissonPBriatBLe FollJHandiness and acceptability of the new ABAK bottle in chronically treated patients. A cross-sectional, retrospective and multicentre studyAnn Pharm Fr2011692229 French21296214
   PubMedGoogle Scholar
• López-GarcíaJSGarcía-LozanoIUse of containers with sterilizing filter in autologous serum eyedropsOphthalmology20121192225223022867978
   PubMed Web of Science ®Google Scholar
• MaychukYFYaniEVNew hyaluronic-acid-based artificial tear drug Hylabak for dry eye therapyJ Cataract Refract Surg2011114850
   Google Scholar
• BrjeskyVVProzornayaLPSadovnikovaNNRadhuanMRNew preservative-free hyaluronic acid preparations in treatment of patients with dry eye syndromeOcular Pharmacology Issues2011IV299104 Russian
   Google Scholar
• PetrayevskyAVTrishkinKSLyovinaOVThe dry eye syndrome in female office workers: a clinical and cytological analysis of results of treatment with HylabakRussian Ophthalmological Journal201224953
   Google Scholar
• NagorskyPGBelkinaVVNesterovaLYEffect of tear-replacement therapy (Hylabac 0.15%) on the dry-eye syndrome intensity in children and adolescents wearing contact lensesRussian Ophthalmology Journal201123236
   Google Scholar
• BrjeskyVVProzornayaLPNew artificial tear preparation Ophtholique in treating patients with dry eye syndrome of different genesisOphthalmological Journal2009II6368 Russian
   Google Scholar
• NornMSDesiccation of the precorneal film. I. Corneal wetting timeActa Ophthalmol1969478658804187469
   PubMed Web of Science ®Google Scholar